Marco Carlo Merlano (Marco Merlano)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Venues

Vaccines

Journal of clinical medicine

Diagnostics (Basel, Switzerland)

Cancer management and research

Candiolo Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Candiolo Cancer Institute Feb 01 2019

Italy

consultant :: medical oncology

S. Croce e Carle teaching hospital Mar 24 1997

Italy

head dept :: medical oncology

Publications

Andrea Abbona, Vincenzo Ricci, Matteo Paccagnella, Cristina Granetto, Fiorella Ruatta, Carolina Cauchi, Danilo Galizia, Michele Ghidini, Nerina Denaro, Marco Carlo Merlano, Ornella Garrone
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. Vaccines 11 (2) (2023)
Marco Carlo Merlano, Matteo Paccagnella, Nerina Denaro, Andrea Abbona, Danilo Galizia, Dario Sangiolo, Loretta Gammaitoni, Erika Fiorino, Silvia Minei, Paolo Bossi, Lisa Licitra, Ornella Garrone
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment. Cancers 15 (21) (2023)
Andrea Abbona, Vincenzo Ricci, Matteo Paccagnella, Cristina Granetto, Fiorella Ruatta, Carolina Cauchi, Danilo Galizia, Michele Ghidini, Nerina Denaro, Marco Carlo Merlano, Ornella Garrone
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. Vaccines 11 (2) (2023)
Nerina Denaro, Cinzia Solinas, Ornella Garrone, Carolina Cauchi, Fiorella Ruatta, Demi Wekking, Andrea Abbona, Matteo Paccagnella, Marco Carlo Merlano, Cristiana Lo Nigro
The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience. Diagnostics (Basel, Switzerland) 12 (11) (2022)
Nerina Denaro, Ornella Garrone, Michele Ghidini, Gianluca Tomasello, Jens Claus Hahne, Marco Carlo Merlano, Laura Deborah Locati
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience. Journal of clinical medicine 11 (24) (2022)
Marco Carlo Merlano, Nerina Denaro, Danilo Galizia, Fiorella Ruatta, Marcella Occelli, Silvia Minei, Andrea Abbona, Matteo Paccagnella, Michele Ghidini, Ornella Garrone
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review. Biomedicines 10 (8) (2022)
Nerina Denaro, Ornella Garrone, Michele Ghidini, Gianluca Tomasello, Jens Claus Hahne, Marco Carlo Merlano, Laura Deborah Locati
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience. Journal of clinical medicine 11 (24) (2022)
Nerina Denaro, Ornella Garrone, Michele Ghidini, Gianluca Tomasello, Jens Claus Hahne, Marco Carlo Merlano, Laura Deborah Locati
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience. Journal of clinical medicine 11 (24) (2022)
Matteo Paccagnella, Andrea Abbona, Andrea Michelotti, Elena Geuna, Fiorella Ruatta, Elisabetta Landucci, Nerina Denaro, Paola Vanella, Cristiana Lo Nigro, Danilo Galizia, Marco Carlo Merlano, Ornella Garrone
Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression. Vaccines 10 (1) (2022)
Valentina D A Corino, Marco Bologna, Giuseppina Calareso, Lisa Licitra, Mariagrazia Ghi, Gaetana Rinaldi, Francesco Caponigro, Franco Morelli, Mario Airoldi, Giacomo Allegrini, Alessandra Cassano, Daris Ferrari, Aurora Mirabile, Alicia Tosoni, Danilo Galizia, Marco Carlo Merlano, Andrea Sponghini, Gabriella Moretti, Luca Mainardi, Paolo Bossi
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study. Diagnostics (Basel, Switzerland) 11 (6) (2021)
Nerina Denaro, Marco Carlo Merlano, Cristiana Lo Nigro
Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis. Cancer management and research 13 (2021)

Marco Carlo Merlano.css-eqlu8i{font-size:small;padding-left:4px;} (Marco Merlano)

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Carlo Merlano (Marco Merlano)